Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity

doi 10.1021/jm0605482.s001